US authorizes the use of dual-variant covid-19 vaccine boosters
The US Food and Drug Administration authorised the use of versions of Moderna and Pfizer/BioNTech covid-19 vaccines that target both the original virus and two omicron subvariants. The US Food and Drug Administration (FDA) granted emergency use authorisation on 31 August to covid-19 vaccines that target two different coronavirus variants. These updated “bivalent” vaccine [...]